HDAC9 and idiopathic pulmonary fibrosis: Several HDACs, primarily members of Classes I and II, play important roles in the progression of IPF and have gained interest in recent years, along with the corresponding HDAC inhibitors that may constitute a new strategy for IPF treatment [13,17].